The end-to-end vaccine supply chain refers to the "one-stop" supply chain model from the transportation of vaccine raw materials to the terminal distribution of vaccine finished products and then to reverse sales and return allocation.
This report aims to provide a comprehensive presentation of the global market for the End-To-End Vaccine Supply Chain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding the End-To-End Vaccine Supply Chain. This report contains market size and forecasts of the End-To-End Vaccine Supply Chain in global, including the following market information:
Global the End-To-End Vaccine Supply Chain Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global the End-To-End Vaccine Supply Chain market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Provide Services Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of the End-To-End Vaccine Supply Chain include SF Express, IBM(IBM Blockchain), AnyLogic, Shanghai Hongqiao Biology Medicine Co,.Ltd., Bureau Veritas, OPTEL, Maersk, KPMG and Gartner, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the the End-To-End Vaccine Supply Chain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global the End-To-End Vaccine Supply Chain Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global the End-To-End Vaccine Supply Chain Market Segment Percentages, by Type, 2022 (%)
Provide Services
Supply Enquiry
Global the End-To-End Vaccine Supply Chain Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global the End-To-End Vaccine Supply Chain Market Segment Percentages, by Application, 2022 (%)
Logistics Industry
Pharmaceutical Industry
Other
Global the End-To-End Vaccine Supply Chain Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global the End-To-End Vaccine Supply Chain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies the End-To-End Vaccine Supply Chain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies the End-To-End Vaccine Supply Chain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SF Express
IBM(IBM Blockchain)
AnyLogic
Shanghai Hongqiao Biology Medicine Co,.Ltd.
Bureau Veritas
OPTEL
Maersk
KPMG
Gartner
Outline of Major Chapters:
Chapter 1: Introduces the definition of the End-To-End Vaccine Supply Chain, market overview.
Chapter 2: Global the End-To-End Vaccine Supply Chain market size in revenue.
Chapter 3: Detailed analysis of the End-To-End Vaccine Supply Chain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of the End-To-End Vaccine Supply Chain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 the End-To-End Vaccine Supply Chain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global the End-To-End Vaccine Supply Chain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global the End-To-End Vaccine Supply Chain Overall Market Size
2.1 Global the End-To-End Vaccine Supply Chain Market Size: 2022 VS 2032
2.2 Global the End-To-End Vaccine Supply Chain Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top the End-To-End Vaccine Supply Chain Players in Global Market
3.2 Top Global the End-To-End Vaccine Supply Chain Companies Ranked by Revenue
3.3 Global the End-To-End Vaccine Supply Chain Revenue by Companies
3.4 Top 3 and Top 5 the End-To-End Vaccine Supply Chain Companies in Global Market, by Revenue in 2022
3.5 Global Companies the End-To-End Vaccine Supply Chain Product Type
3.6 Tier 1, Tier 2 and Tier 3 the End-To-End Vaccine Supply Chain Players in Global Market
3.6.1 List of Global Tier 1 the End-To-End Vaccine Supply Chain Companies
3.6.2 List of Global Tier 2 and Tier 3 the End-To-End Vaccine Supply Chain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global the End-To-End Vaccine Supply Chain Market Size Markets, 2022 & 2032
4.1.2 Provide Services
4.1.3 Supply Enquiry
4.2 By Type - Global the End-To-End Vaccine Supply Chain Revenue & Forecasts
4.2.1 By Type - Global the End-To-End Vaccine Supply Chain Revenue, 2018-2023
4.2.2 By Type - Global the End-To-End Vaccine Supply Chain Revenue, 2024-2032
4.2.3 By Type - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global the End-To-End Vaccine Supply Chain Market Size, 2022 & 2032
5.1.2 Logistics Industry
5.1.3 Pharmaceutical Industry
5.1.4 Other
5.2 By Application - Global the End-To-End Vaccine Supply Chain Revenue & Forecasts
5.2.1 By Application - Global the End-To-End Vaccine Supply Chain Revenue, 2018-2023
5.2.2 By Application - Global the End-To-End Vaccine Supply Chain Revenue, 2024-2032
5.2.3 By Application - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global the End-To-End Vaccine Supply Chain Market Size, 2022 & 2032
6.2 By Region - Global the End-To-End Vaccine Supply Chain Revenue & Forecasts
6.2.1 By Region - Global the End-To-End Vaccine Supply Chain Revenue, 2018-2023
6.2.2 By Region - Global the End-To-End Vaccine Supply Chain Revenue, 2024-2032
6.2.3 By Region - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America the End-To-End Vaccine Supply Chain Revenue, 2018-2032
6.3.2 US the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.3.3 Canada the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.3.4 Mexico the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe the End-To-End Vaccine Supply Chain Revenue, 2018-2032
6.4.2 Germany the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.3 France the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.4 U.K. the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.5 Italy the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.6 Russia the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.7 Nordic Countries the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.4.8 Benelux the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia the End-To-End Vaccine Supply Chain Revenue, 2018-2032
6.5.2 China the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.5.3 Japan the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.5.4 South Korea the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.5.5 Southeast Asia the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.5.6 India the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America the End-To-End Vaccine Supply Chain Revenue, 2018-2032
6.6.2 Brazil the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.6.3 Argentina the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa the End-To-End Vaccine Supply Chain Revenue, 2018-2032
6.7.2 Turkey the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.7.3 Israel the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.7.4 Saudi Arabia the End-To-End Vaccine Supply Chain Market Size, 2018-2032
6.7.5 UAE the End-To-End Vaccine Supply Chain Market Size, 2018-2032
7 the End-To-End Vaccine Supply Chain Companies Profiles
7.1 SF Express
7.1.1 SF Express Company Summary
7.1.2 SF Express Business Overview
7.1.3 SF Express the End-To-End Vaccine Supply Chain Major Product Offerings
7.1.4 SF Express the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.1.5 SF Express Key News & Latest Developments
7.2 IBM(IBM Blockchain)
7.2.1 IBM(IBM Blockchain) Company Summary
7.2.2 IBM(IBM Blockchain) Business Overview
7.2.3 IBM(IBM Blockchain) the End-To-End Vaccine Supply Chain Major Product Offerings
7.2.4 IBM(IBM Blockchain) the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.2.5 IBM(IBM Blockchain) Key News & Latest Developments
7.3 AnyLogic
7.3.1 AnyLogic Company Summary
7.3.2 AnyLogic Business Overview
7.3.3 AnyLogic the End-To-End Vaccine Supply Chain Major Product Offerings
7.3.4 AnyLogic the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.3.5 AnyLogic Key News & Latest Developments
7.4 Shanghai Hongqiao Biology Medicine Co,.Ltd.
7.4.1 Shanghai Hongqiao Biology Medicine Co,.Ltd. Company Summary
7.4.2 Shanghai Hongqiao Biology Medicine Co,.Ltd. Business Overview
7.4.3 Shanghai Hongqiao Biology Medicine Co,.Ltd. the End-To-End Vaccine Supply Chain Major Product Offerings
7.4.4 Shanghai Hongqiao Biology Medicine Co,.Ltd. the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.4.5 Shanghai Hongqiao Biology Medicine Co,.Ltd. Key News & Latest Developments
7.5 Bureau Veritas
7.5.1 Bureau Veritas Company Summary
7.5.2 Bureau Veritas Business Overview
7.5.3 Bureau Veritas the End-To-End Vaccine Supply Chain Major Product Offerings
7.5.4 Bureau Veritas the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.5.5 Bureau Veritas Key News & Latest Developments
7.6 OPTEL
7.6.1 OPTEL Company Summary
7.6.2 OPTEL Business Overview
7.6.3 OPTEL the End-To-End Vaccine Supply Chain Major Product Offerings
7.6.4 OPTEL the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.6.5 OPTEL Key News & Latest Developments
7.7 Maersk
7.7.1 Maersk Company Summary
7.7.2 Maersk Business Overview
7.7.3 Maersk the End-To-End Vaccine Supply Chain Major Product Offerings
7.7.4 Maersk the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.7.5 Maersk Key News & Latest Developments
7.8 KPMG
7.8.1 KPMG Company Summary
7.8.2 KPMG Business Overview
7.8.3 KPMG the End-To-End Vaccine Supply Chain Major Product Offerings
7.8.4 KPMG the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.8.5 KPMG Key News & Latest Developments
7.9 Gartner
7.9.1 Gartner Company Summary
7.9.2 Gartner Business Overview
7.9.3 Gartner the End-To-End Vaccine Supply Chain Major Product Offerings
7.9.4 Gartner the End-To-End Vaccine Supply Chain Revenue in Global Market (2018-2023)
7.9.5 Gartner Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. the End-To-End Vaccine Supply Chain Market Opportunities & Trends in Global Market
Table 2. the End-To-End Vaccine Supply Chain Market Drivers in Global Market
Table 3. the End-To-End Vaccine Supply Chain Market Restraints in Global Market
Table 4. Key Players of the End-To-End Vaccine Supply Chain in Global Market
Table 5. Top the End-To-End Vaccine Supply Chain Players in Global Market, Ranking by Revenue (2022)
Table 6. Global the End-To-End Vaccine Supply Chain Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global the End-To-End Vaccine Supply Chain Revenue Share by Companies, 2018-2023
Table 8. Global Companies the End-To-End Vaccine Supply Chain Product Type
Table 9. List of Global Tier 1 the End-To-End Vaccine Supply Chain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 the End-To-End Vaccine Supply Chain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - the End-To-End Vaccine Supply Chain Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - the End-To-End Vaccine Supply Chain Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - the End-To-End Vaccine Supply Chain Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - the End-To-End Vaccine Supply Chain Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global the End-To-End Vaccine Supply Chain Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global the End-To-End Vaccine Supply Chain Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2024-2032
Table 30. SF Express Company Summary
Table 31. SF Express the End-To-End Vaccine Supply Chain Product Offerings
Table 32. SF Express the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 33. SF Express Key News & Latest Developments
Table 34. IBM(IBM Blockchain) Company Summary
Table 35. IBM(IBM Blockchain) the End-To-End Vaccine Supply Chain Product Offerings
Table 36. IBM(IBM Blockchain) the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 37. IBM(IBM Blockchain) Key News & Latest Developments
Table 38. AnyLogic Company Summary
Table 39. AnyLogic the End-To-End Vaccine Supply Chain Product Offerings
Table 40. AnyLogic the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 41. AnyLogic Key News & Latest Developments
Table 42. Shanghai Hongqiao Biology Medicine Co,.Ltd. Company Summary
Table 43. Shanghai Hongqiao Biology Medicine Co,.Ltd. the End-To-End Vaccine Supply Chain Product Offerings
Table 44. Shanghai Hongqiao Biology Medicine Co,.Ltd. the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 45. Shanghai Hongqiao Biology Medicine Co,.Ltd. Key News & Latest Developments
Table 46. Bureau Veritas Company Summary
Table 47. Bureau Veritas the End-To-End Vaccine Supply Chain Product Offerings
Table 48. Bureau Veritas the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 49. Bureau Veritas Key News & Latest Developments
Table 50. OPTEL Company Summary
Table 51. OPTEL the End-To-End Vaccine Supply Chain Product Offerings
Table 52. OPTEL the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 53. OPTEL Key News & Latest Developments
Table 54. Maersk Company Summary
Table 55. Maersk the End-To-End Vaccine Supply Chain Product Offerings
Table 56. Maersk the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 57. Maersk Key News & Latest Developments
Table 58. KPMG Company Summary
Table 59. KPMG the End-To-End Vaccine Supply Chain Product Offerings
Table 60. KPMG the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 61. KPMG Key News & Latest Developments
Table 62. Gartner Company Summary
Table 63. Gartner the End-To-End Vaccine Supply Chain Product Offerings
Table 64. Gartner the End-To-End Vaccine Supply Chain Revenue (US$, Mn) & (2018-2023)
Table 65. Gartner Key News & Latest Developments
List of Figures
Figure 1. the End-To-End Vaccine Supply Chain Segment by Type in 2022
Figure 2. the End-To-End Vaccine Supply Chain Segment by Application in 2022
Figure 3. Global the End-To-End Vaccine Supply Chain Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global the End-To-End Vaccine Supply Chain Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global the End-To-End Vaccine Supply Chain Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by the End-To-End Vaccine Supply Chain Revenue in 2022
Figure 8. By Type - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 9. By Application - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 10. By Type - Global the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 12. By Application - Global the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 14. By Region - Global the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 15. By Country - North America the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 16. US the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 17. Canada the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 20. Germany the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 21. France the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 23. Italy the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 24. Russia the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 28. China the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 29. Japan the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 32. India the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 34. Brazil the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa the End-To-End Vaccine Supply Chain Revenue Market Share, 2018-2032
Figure 37. Turkey the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 38. Israel the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 40. UAE the End-To-End Vaccine Supply Chain Revenue, (US$, Mn), 2018-2032
Figure 41. SF Express the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. IBM(IBM Blockchain) the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AnyLogic the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Shanghai Hongqiao Biology Medicine Co,.Ltd. the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bureau Veritas the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. OPTEL the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Maersk the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. KPMG the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Gartner the End-To-End Vaccine Supply Chain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
